These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24875819)

  • 1. Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.
    Wu JP; Huang WB; Zhou H; Xu LW; Zhao JH; Zhu JG; Su JH; Sun HB
    Asian J Androl; 2014; 16(5):710-4. PubMed ID: 24875819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity of stromal changes predicts biochemical recurrence-free survival in prostatic carcinoma.
    Tomas D; Spajić B; Milosević M; Demirović A; Marusić Z; Kruslin B
    Scand J Urol Nephrol; 2010 Nov; 44(5):284-90. PubMed ID: 20459359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
    Ayala G; Tuxhorn JA; Wheeler TM; Frolov A; Scardino PT; Ohori M; Wheeler M; Spitler J; Rowley DR
    Clin Cancer Res; 2003 Oct; 9(13):4792-801. PubMed ID: 14581350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypic differences of stroma cells in benign and malignant human prostate tissues].
    Zhou H; Sun HB; Huang WB; Xu Z; Su JH; Zhu JG; Jia RP; Liu J
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):516-9. PubMed ID: 22490152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
    Wikström P; Marusic J; Stattin P; Bergh A
    Prostate; 2009 Jun; 69(8):799-809. PubMed ID: 19189305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
    Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
    Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
    Yanagisawa N; Li R; Rowley D; Liu H; Kadmon D; Miles BJ; Wheeler TM; Ayala GE
    Hum Pathol; 2007 Nov; 38(11):1611-20. PubMed ID: 17868773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma.
    Tomas D; Kruslin B
    Prostate; 2004 Dec; 61(4):324-31. PubMed ID: 15389817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast as a critical stromal cell type determining prognosis in prostate cancer.
    Blom S; Erickson A; Östman A; Rannikko A; Mirtti T; Kallioniemi O; Pellinen T
    Prostate; 2019 Sep; 79(13):1505-1513. PubMed ID: 31269283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma.
    Tomas D; Ulamec M; Hudolin T; Bulimbasić S; Belicza M; Kruslin B
    Prostate Cancer Prostatic Dis; 2006; 9(4):414-9. PubMed ID: 16652121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.
    Hägglöf C; Hammarsten P; Josefsson A; Stattin P; Paulsson J; Bergh A; Ostman A
    PLoS One; 2010 May; 5(5):e10747. PubMed ID: 20505768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells.
    Silva MM; Matheus WE; Garcia PV; Stopiglia RM; Billis A; Ferreira U; Fávaro WJ
    Int Braz J Urol; 2015; 41(5):849-58. PubMed ID: 26689510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.
    Guan Y; Wu Y; Liu Y; Ni J; Nong S
    Prostate; 2016 Aug; 76(11):986-93. PubMed ID: 27040772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
    Sharpe B; Alghezi DA; Cattermole C; Beresford M; Bowen R; Mitchard J; Chalmers AD
    Prostate; 2017 May; 77(13):1312-1324. PubMed ID: 28744948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma on needle prostatic biopsies: does reactive stroma predicts biochemical recurrence in patients following radical prostatectomy?
    Billis A; Meirelles L; Freitas LL; Polidoro AS; Fernandes HA; Padilha MM; Magna LA; Reis LO; Ferreira U
    Int Braz J Urol; 2013; 39(3):320-7. PubMed ID: 23849565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
    Yang Z; Peng YC; Gopalan A; Gao D; Chen Y; Joyner AL
    Dis Model Mech; 2017 Jan; 10(1):39-52. PubMed ID: 27935821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.
    Singer E; Linehan J; Babilonia G; Imam SA; Smith D; Loera S; Wilson T; Smith S
    PLoS One; 2013; 8(6):e60562. PubMed ID: 23762225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.